Clinical usefulness of plasma 1,5-anhydroglucitol, fructosamine and blood HbAlc level in mice with abnormal glucose metabolism and in controls

被引:0
|
作者
Tabata H. [1 ,3 ]
Kubo M. [2 ]
Suzuki H. [1 ]
Matsuzawa T. [2 ]
Kariya K. [1 ]
机构
[1] Yamanouchi Pharmaceutical Co. Ltd, Tokyo
[2] Faculty of Pharmaceutical Sciences, Kobegakuin University, Nishi-ku, Kobe
[3] Safety Research Laboratories, Yamanouchi Pharmaceutical Co. Ltd., Itabashi-ku, Tokyo 174-8511
来源
关键词
1,5-anhydroglucitol; Blood glucose; Fructosamine; Glycaemic marker; Haemoglobin alc; Mice;
D O I
10.1007/BF02585515
中图分类号
学科分类号
摘要
We compared the usefulness of blood measurements of 1,5-anhydroglucitol (1,5-AG), fructosamine and blood haemoglobin Alc (HbA|C) levels in C57BL/KsJ mice with abnormal glucose metabolism and in controls. Both streptozotocin (STZ)-induced diabetic mice (db/m genotype) and genetically diabetic mice (db/ db genotype) displaying a hyperglycaemia, plasma 1,5AG level fell rapidly and dramatically. In contrast, both fructosamine and HbAlc increased so gradually that they provided an approximation of glycaemic conditions over a few weeks. Food-restricted mice displayed a slight hypoglycaemia, with fructosamine and HbAic level reducing slightly but significantly at 4 and 12 weeks, respectively after commencement of treatment. These three glycaemic parameters were significantly correlated with blood glucose, suggesting that these three glycaemic parameters are specifically related to the abnormal glucose metabolism, and that their routine examination in mice may help delineate the metabolic derangement in the disease or provide analytical information in preclinical studies. © 1999 Springer-Verlag London Limited.
引用
收藏
页码:7 / 12
页数:5
相关论文
共 30 条
  • [1] Clinical usefulness of plasma 1,5-anhydroglucitol, fructosamine and blood HbA1c level in mice with abnormal glucose metabolism and in controls
    Tabata, H
    Kubo, M
    Suzuki, H
    Matsuzawa, T
    Kariya, K
    COMPARATIVE HAEMATOLOGY INTERNATIONAL, 1999, 9 (01): : 7 - 12
  • [2] CHANGES IN RELATIONSHIP BETWEEN BLOOD-GLUCOSE LEVEL AND PLASMA 1,5-ANHYDROGLUCITOL LEVEL IN KK MICE
    AOYAGI, T
    AKANUMA, H
    WADA, T
    SAKAGUCHI, T
    KOBAYASHI, T
    UMEZAWA, H
    BIOCHEMISTRY INTERNATIONAL, 1989, 18 (03): : 599 - 603
  • [3] Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control
    Yamanouchi, T
    Ogata, N
    Tagaya, T
    Kawasaki, T
    Sekino, N
    Funato, H
    Akaoka, I
    Miyashita, H
    LANCET, 1996, 347 (9014): : 1514 - 1518
  • [4] PLASMA 1,5-ANHYDROGLUCITOL IN SUBJECTS WITH VARIOUS GLUCOSE-TOLERANCE
    POPPSNIJDERS, C
    CROMME, PVM
    GEENEN, B
    VANDERVEEN, EA
    DIABETOLOGIA, 1986, 29 (08) : A583 - A583
  • [5] Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose
    Kilpatrick, ES
    Keevil, BG
    Richmond, KL
    Newland, P
    Addison, GM
    DIABETIC MEDICINE, 1999, 16 (06) : 496 - 499
  • [6] Decreased Serum 1,5-Anhydroglucitol Level Is Associated with Development of Abnormal Glucose Metabolism or Metabolic Syndrome in Male Japanese: Tokushima Cohort Study
    Hata, Akiko
    Aki, Nanako
    Ichihara, Takako
    Tamura, Ayako
    Minagawa, Takako
    Kuwamura, Yumi
    Funaki, Makoto
    DIABETES, 2020, 69
  • [7] 1,5-Anhydroglucitol levels are low irrespective of plasma glucose levels in patients with chronic liver disease
    Koga, Masafumi
    Murai, Jun
    Saito, Hiroshi
    Mukai, Mikio
    Toya, Daishu
    Tanaka, Nobuyoshi
    Kanehara, Hideo
    Bando, Yukihiro
    Kasayama, Soji
    ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 : 121 - 125
  • [8] Habitual intake of dairy products influences serum 1,5-anhydroglucitol levels independently of plasma glucose
    Koga, Masafumi
    Murai, Jun
    Saito, Hiroshi
    Mukai, Mikio
    Kasayama, Soji
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (01) : 122 - 125
  • [9] Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial
    Selvin, Elizabeth
    Wang, Dan
    McEvoy, John William
    Juraschek, Stephen P.
    Lazo, Mariana
    Hamet, Pavel
    Cooper, Mark E.
    Marre, Michel
    Williams, Bryan
    Harrap, Stephen
    Chalmers, John
    Woodward, Mark
    DIABETES OBESITY & METABOLISM, 2019, 21 (08): : 2017 - 2023
  • [10] Clinical application of the serum 1,5-anhydroglucitol assay method using glucose 3-dehydrogenase
    Hamafuji, T
    Tsugawa, W
    Sode, K
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2002, 16 (06) : 299 - 303